Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3CNS 3Genitourinary 2Gastrointestinal 2Other hematologic neoplasm 1Other 1

Conditions

Brain Neoplasms 1899Glioblastoma 1791Glioma 1126Central Nervous System Neoplasms 599Astrocytoma 593Neuroblastoma 552Gliosarcoma 465Oligodendroglioma 363Neoplasms 312Breast Neoplasms 273Medulloblastoma 272Carcinoma, Non-Small-Cell Lung 225Recurrence 198Sarcoma 183Neoplasm Metastasis 183Melanoma 181Meningioma 177Ependymoma 174Lung Neoplasms 156Lymphoma 133Osteosarcoma 126Meningeal Carcinomatosis 126Neurofibromatosis 1 114Wilms Tumor 111Ovarian Neoplasms 110Diffuse Intrinsic Pontine Glioma 105Precursor Cell Lymphoblastic Leukemia-Lymphoma 103Rhabdomyosarcoma 100Lymphoma, Non-Hodgkin 96Burkitt Lymphoma 89

Interventions

Dexmedetomidine 3Sodium Chloride 2Saline Solution 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Delirium × CNS × Clear all
NCT07398066 2026-02-09

DEX-NEURO

University of Malaya

Phase NA Not yet recruiting
60 enrolled
CNS

Brain Neoplasms, Delirium, Meningioma, Pain

NCT04399343 2021-01-28

DEPOD

Capital Medical University

Phase 4 Unknown
700 enrolled
CNS

Central Nervous System Diseases, Delirium

NCT04494828 2021-01-12

Impact Dexmedetomidine on Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor

Capital Medical University

Phase 4 Completed
60 enrolled
CNS

Central Nervous System Diseases, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡